Cell Counting Kit-8 (CCK-8)
目录号 : GK10001细胞计数试剂盒-8(CCK-8)是一种即用型的单瓶溶液,可快速、可靠地测量各种化学物质对细胞存活率和毒性的敏感度。
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2025):2413968.PMID:40223457
- Adv Fiber Mater (2025):1-17.
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Bioact Mater 51 (2025):825-840.PMID:40678266
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Matter (2025).
- Trends in Sciences 22.9 (2025):10417-10417.
- Cancer Res 85.20 (2025).PMID:40729488
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Res (2025).PMID:40729488
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 14.1 (2023):3877.PMID:37391428
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Acs Nano (2024).PMID:39361472
- Nat Commun 16.1 (2025):7650.PMID:40819125
- Acs Nano (2025).PMID:40878028
- ACS nano (2025).PMID:39846120
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Nat Commun 16.1 (2025):6271.PMID:40623997
- Nat Commun 16.1 (2025):6532.PMID:40664636
- Acs Nano (2025).PMID:40534228
- Cancer Commun (2024).PMID:38512764
- Nat. Commun. 16.1 (2025):7856.PMID:40846856
- Nat Commun 16.1 (2025):7827.PMID:40846845
- Nat Commun 16.1 (2025):6100.PMID:40603843
- Nat Commun 16.1 (2025):6807.PMID:40707439
- Adv Sci (2024):2401845.PMID:38757623
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Brain Behav Immun (2024).PMID:38565398
- Adv Sci (2023):2301107.PMID:37097746
- Autophagy just-accepted (2024).PMID:39007910
- Acta Pharm Sin B (2025).
- Nat. Commun. 16.1 (2025):2551.
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Acta Pharm Sin B (2025).
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2025):e08503.PMID:40685704
- Adv Sci (2025):e02781.PMID:40886326
- Adv Sci (2025):2417374.PMID:40213972
- Adv Sci (2025):2417374.PMID:40213972
- Adv Sci (2024):2404365.PMID:39159143
- Adv Sci (2024):2402450.PMID:38952061
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):2413936.PMID:40047320
- Advanced Science (2025):e08503.PMID:40685704
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2025):e04192.PMID:40536697
- Science Advances 11.31 (2025):eadx6732.PMID:40737412
- Small (2024):2407674.PMID:39363789
- J Adv Res (2025).PMID:40373960
- Exp Mol Med (2025):1-15.PMID:40887495
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Small 21.3 (2025):2409121.PMID:39544127
- Biomaterials (2025):123335.PMID:40222258
- Theranostics 15.15 (2025):7802.PMID:40756352
- Sci Adv 11.33 (2025):eadx3851.PMID:40802748
- Theranostics 15.15 (2025):7820.PMID:40756354
- Theranostics 15.15 (2025):7802.PMID:40756352
- J Nanobiotechnol 23.1 (2025):533.PMID:40691611
- Theranostics 15.14 (2025):6919.PMID:40585994
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Biomaterials (2025):123539.PMID:40664088
- Carbohyd Polym (2025):124445.
- J Nanobiotechnol 23.1 (2025):537.PMID:40707955
- J Adv Res (2023).PMID:36933884
- J Nanobiotechnol (2025).PMID:40691611
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Water Res (2024):121379.PMID:38422694
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- Microbiome 13.1 (2025):1-19.PMID:41063317
- Biomaterials 325 (2026):123539.PMID:40664088
- Nano Today 61 (2025):102560.
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Mol Ther (2025).PMID:39810420
- Redox Biology (2025):103870.
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- J Control Release (2025):114187.PMID:40902670
- Redox Biol (2025):103771.PMID:40669208
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mater Horiz (2024).PMID:39189308
- Small Methods (2024):2400223.PMID:38602202
- Mater Horiz (2024).PMID:39189308
- J Hazard Mater (2024):135904.PMID:39303616
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Theranostics 12.7 (2022):3488.PMID:35547749
- Engineering-Prc (2025).
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- J Control Release 359 (2023):12-25.PMID:37244298
- Cell Rep Med 6.9 (2025).PMID:40961922
- EBioMedicine 99 (2024).PMID:38101299
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- J Control Release 373 (2024):749-765.PMID:39084465
- Redox Biol (2023):102983.PMID:38064762
- J Control Release 365 (2024):301-316.PMID:38007195
- Research-China (2025).
- J Control Release 360 (2023):647-659.PMID:37406817
- Cell Discov 6.1 (2020):96.PMID:33349633
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Adv Res (2025).PMID:40373960
- Environ Sci Technol (2024).PMID:39364562
- J Control Release 379 (2025):89-104.PMID:39756690
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Redox Biol 62 (2023):102663.PMID:36924682
- J Control Release 349 (2022):254-268.PMID:35803328
- Water Res (2024):122403.PMID:39278116
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- Environ Sci Technol (2025).PMID:40743993
- Research-China (2025).
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- Research-China 8 (2025):0823.PMID:40822127
- Environmental Science & Technology (2025).PMID:40743993
- Cardiovascular Diabetology 24.1 (2025):338.PMID:40826463
- Medcomm 6.9 (2025):e70365.PMID:40919132
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Research 8 (2025):0860.PMID:40862056
- Research 8 (2025):0854.PMID:40927753
- J Adv Res (2025).
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Adv Healthc Mater (2025):2500845.PMID:40400499
- Sci Total Environ 897 (2023):165514.PMID:37451464
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Mater Today Bio (2025):102288.PMID:40978162
- Acta Biomater (2025).PMID:40946735
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- Rare Met. (2025):1-23.
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Cell Death Dis (2025):680.PMID:41053142
- Adv Healthc Mater (2024):2401061.PMID:38849128
- Mater Today Bio 32 (2025):101703.PMID:40230646
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Cancer Lett (2024):216765.PMID:38408604
- Adv Healthc Mater (2025):e01742.PMID:40751487
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Cell Death Dis 16.1 (2025):634.PMID:40841355
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Food Chem (2025):146103.PMID:18830861
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- Cell Death Dis 16.1 (2025):493.PMID:40615369
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Acta Biomater (2024).PMID:38452962
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Mater Today Bio (2025):102288.
- Cancer Lett 620 (2025):217685.PMID:40158720
- Mater Today Bio (2025):101901.PMID:40520551
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- ENGINEERING-PRC (2025).
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- View-China (2025):20240103.
- Food Chem (2024):139505.PMID:38703732
- Pharmacol Res (2024):107460.PMID:39393436
- Biomark Res 11.1 (2023):3PMID:36611218
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Acs Appl Mater Inter (2024).PMID:38345297
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Brit J Cancer (2024):1-9.PMID:38594370
- Acta Biomater (2025).PMID:39952883
- Cancer Lett 611 (2025):217418.PMID:39725146
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Acta Biomater (2025).PMID:40024424
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Int J Biol Macromol (2025):146723.PMID:40784392
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Mater. Today Bio (2025):101703.
- CANCER LETT (2025):217685.
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Genes Dis (2025):101732.PMID:37815978
- J Colloid Interf Sci (2025):.PMID:39755016
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Acs Appl Mater Inter 15.32 (2023).PMID:37542453
- Front Immunol 14 (2023):1130308.PMID:37006248
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Environ Pollut 338 (2023):122581.PMID:37748638
- Environ Pollut 334 (2023):122148.PMID:37419204
- J Colloid Interf Sci (2025):137652.
- Cancer Lett (2024):217418.PMID:39725146
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Acs Sensors (2024).PMID:38958530
- Int J Biol Macromol (2024):133667.PMID:38969038
- Phytomedicine 118 (2023):154944.PMID:37393830
- Food Res Int 204 (2025):115940.PMID:39986784
- Int J Biol Sci 21.4 (2025):1837-1851.
- Int J Biol Macromol (2025):147767.PMID:40972920
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Acs Appl Mater Inter (2025).PMID:40025657
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Int J Biol Macromol (2025):141146.PMID:39986528
- Acta Pharmacol. Sin. (2025):1-13.PMID:40903541
- Int J Biol Macromol (2025):141767.
- Nanoscale Horiz (2025).
- Oncogene (2023):1-13.PMID:37138031
- Phytomedicine (2025):157223.PMID:40929882
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Int J Biol Macromol (2025):147167.PMID:40889659
- Free Radical Bio Med (2025).PMID:40782974
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Npj Precis Oncol 9.1 (2025):269.PMID:40753128
- Acs Appl Mater Inter (2024).PMID:39448903
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol (2025):145368PMID:40541884
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Free Radical Bio Med (2025).PMID:40782974
- Int J Biol Macromol (2025):148033.PMID:41038469
- Int J Biol Macromol(2023):125130.PMID:37263336
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2025):140602.PMID:39922352
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Phytomedicine (2023):155270.PMID:38096717
- Acs Appl Mater Inter (2025).PMID:39853325
- Int J Biol Macromol (2024):129172.PMID:38176496
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Environ Res (2024):118221.PMID:38246300
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Int J Biol Macromol (2024):137561.PMID:39537068
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Int J Biol Macromol (2024):135562.PMID:39276884
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Antivir Res 205 (2022):105381.PMID:35835291
- Int J Biol Macromol (2024):131928.PMID:38688339
- Sci China Life Sci (2025):1-11.PMID:39821161
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J Biol Macromol (2025):140632.PMID:39909240
- Int J Biol Macromol (2025):148198.PMID:41072677
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Phytomedicine (2025):157371.
- Mater Today Bio (2024):101019.PMID:38516170
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Mater Today Bio (2025):101901.
- Acs Omega (2025).
- Int. J. Biol. Macromol. (2025):143759.
- Acs Appl Mater Inter (2024).PMID:39320506
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Int J Biol Macromol (2024):135979.PMID:39332550
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Front Immunol 16 (2025):1569210.PMID:40396173
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- CANCER IMMUNOL RES (2025).PMID:40323348
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Iscience (2025).
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Neural Regen Res (2025):10-4103.PMID:41017682
- Neural Regen Res (2025):10-4103.PMID:41017725
- Phytomedicine (2025):156860.
- Cell Death Discov 11.1 (2025):427.PMID:41052997
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Virol Sin (2023).PMID:37331658
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Oncogene (2025):1-15.PMID:39920289
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Cell Rep 44.3 (2025).PMID:39977268
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Life Sci 308 (2022):120925.PMID:36057399
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Int J Nanomed (2025):11295-11314.PMID:40989888
- Front Immunol 14 (2023).PMID:37662906
- Int J Nanomed 20 (2025):293-308.
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Phytomedicine 130 (2024):155744.PMID:38763011
- J Anim Sci Biotechno 16.1 (2025):121.PMID:40887645
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Stem Cell Res Ther 16.1 (2025):239.PMID:40361250
- Food Res Int (2025):115940.
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Diabetes (2025):db250132.PMID:40906541
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Oncogene (2025):1-17.PMID:40968253
- Front Immunol 13 (2022):902515.PMID:35874682
- J Med Chem (2024).PMID:39292661
- J Gastroenterol (2023):1-14.PMID:37150773
- Life Sci 312 (2023):121092.PMID:36279968
- Phytomedicine (2025):156598.
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- J Environ Chem Eng 13.3 (2025):116286.
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- J Med Virol 97.3 (2025):e70267.
- Phytomedicine (2024):155859.PMID:38972239
- Phytomedicine (2025):156515.PMID:39983438
- Chem-Biol Interact (2025):111576.PMID:40456372
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Fertil Steril (2023).PMID:37178109
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- AGING DIS 17.1 (2026):2.PMID:40072367
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Phytother Res (2024).PMID:38558449
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- J Med Chem (2025).PMID:40500735
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Arch Toxicol (2025):1-17.PMID:40464975
- J Med Chem 68.3 (2025):3356-3372.PMID:39842821
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Emerg Microbes Infec (2025):2522877.PMID:40536397
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- J Med Chem (2024).PMID:38315032
- Embo Rep (2025):1-23. PMID:40185977
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Front Nutr 9 (2022):812623.PMID:35419394
- Free Radical Bio Med (2024).PMID:38367927
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- J Med Chem (2025).PMID:39842821
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Front Immunol 13 (2022):986214.PMID:36341437
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- J Polym Environ (2025):1-16.
- Antioxidants-Basel 14.8 (2025):915.
- J. Environ. Chem. Eng. (2025):116286.
- Biomed Pharmacother 189 (2025):118248.PMID:40561593
- Brit J Pharmacol (2024).PMID:38715438
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Phytomedicine (2025):156928.
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Front Immunol 14 (2023):1111494.PMID:36817451
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Front Immunol 16 (2025):1569210.
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Exp Neurol 359 (2023):114266.PMID:36336032
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Am J Chinese Med (2024):1-23.PMID:38490807
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int J Mol Med 55.3 (2025):1-17.
- J Agr Food Chem (2023).PMID:37922022
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Antioxid Redox Sign (2025).PMID:40455659
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Front Immunol 15 (2024):1375781.PMID:39391314
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Mol Med 31.1 (2025):1-15.PMID:40369420
- J Agr Food Chem 73.14 (2025).PMID:40152883
- Mol Med 30.1 (2024):14.PMID:38254010
- J Invest Dermatol (2025).PMID:39892773
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Front Immunol 15 (2024):1375781.PMID:39391314
- Biochem Pharmacol (2024):116044.PMID:38336157
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- J Gastroenterol (2025):1-17.PMID:41060436
- J Transl Med 23.1 (2025):131.PMID:39885513
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Talanta (2025):127591.PMID:39847915
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Front Pharmacol 11 (2020):16.PMID:32140106
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Front Oncol 12 (2022):858598.PMID:35321435
- Life Sci (2024):122483.PMID:38307238
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- J Nutr Biochem (2024):109678.PMID:38844080
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Front Oncol 12 (2022):770628.PMID:35372056
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Acs Biomater Sci Eng (2024).PMID:38446137
- Mbio (2023):e01688-23.PMID:37882780
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Front Oncol 12 (2022):858598.PMID:35321435
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Mol Med 31.1 (2025):258.PMID:40681992
- Phytother Res (2025).PMID:40675558
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Apoptosis (2024):1-19.PMID:39097858
- Mol Med 31.1 (2025):200.PMID:40405066
- Cells 11.23 (2022):3816.PMID:36497076
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Biochem Pharmacol (2023):115632.PMID:37263300
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Front Immunol 16 (2025):1619733.PMID:40842984
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front. Immunol. 16 (2025):1556715.
- J Agr Food Chem (2025).PMID:40152883
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Cells 11.24 (2022):4094.PMID:36552856
- MOL MED 31.1 (2025):126.PMID:40186145
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Cns Neurosci Ther (2023).PMID:37452510
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Front Immunol 16 (2025):1591912.
- Jci insight 9.15 (2024):PMID:38935435
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Cell Biosci 15.1 (2025):95.PMID:40615893
- Int J Pharmaceut (2023):123142.PMID:37328119
- J Mater Chem B (2024).PMID:39119756
- J Invest Dermatol (2025).PMID:39892773
- Front Immunol 16 (2025):1618342.
- Mol Med 30 (2024):260.PMID:39707194
- Front Immunol 16 (2025):1521965.PMID:40191190
- Mol Med 31.1 (2025):188.PMID:40369420
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Biomacromolecules (2025).
- Front Immunol 16 (2025):1591912.PMID:40655141
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Biomater Adv (2024):214069.PMID:39447240
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Lab Chip (2024).PMID:38939907
- Front Immunol 15 (2024):1455996.PMID:39376562
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- J Agr Food Chem (2025).PMID:40899763
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Acs Biomater Sci Eng (2024).PMID:38445959
- Mol Cell Proteomics (2025):100930.PMID:40024376
- Acs Biomater Sci Eng (2025).PMID:40891613
- Biomater Adv (2025):214257.PMID:40023084
- J Agr Food Chem (2025).PMID:40017402
- Microbiol Res (2025):128183.
- Jci Insight (2024). PMID:38935435
- Phytother Res (2023).PMID:37246830
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- Front Oncol 13 (2023):1132424.PMID:37251940
- J Agr Food Chem (2025).PMID:39962827
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Apoptosis (2025):1-17.PMID:40347321
- Phytother Res (2023).PMID:37086359
- Resp Res 24.1 (2023):216.PMID:37674165
- Front Oncol 13 (2023):1120103.PMID:36959804
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Microbiol Res (2024):127927.PMID:39393129
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- J Ethnopharmacol (2023):116731.PMID:37277084
- Molecules 27.23 (2022):8568.PMID:36500666
- Cell Signal (2023):110987.PMID:38029946
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Molecules 27.17 (2022):5698.PMID:36080465
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Ethnopharmacol (2024):117958.PMID:38395179
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Molecules 28.6 (2023):2426.PMID:36985397
- Front Oncol 12 (2022):996080.PMID:36483054
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Cell Signal 113 (2024):110962.PMID:37931691
- Transl Oncol 56 (2025):102396.PMID:40239242
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Molecules 27.21 (2022):7183.PMID:36364008
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- J Oncol 2022 (2022):6459029PMID:36199788
- J Oncol 2022 (2022).PMID:36213838
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- J Ethnopharmacol (2024):119272.PMID:39716512
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- ACS Appl. Nano Mater. (2025).
- J Ethnopharmacol (2024):117985.PMID:38417600
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Radiother Oncol (2024):110686.PMID:39709027
- J Nutr Biochem (2024):109780.PMID:39395694
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Transl Oncol 52 (2025):102256.PMID:39733744
- Front Oncol 12 (2022):1043161.PMID:36439418
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- J Virol (2023):e00549-23.PMID:37222617
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Molecules 27.14 (2022):4603.PMID:35889477
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- J Oncol 2022 (2022).PMID:36213831
- Glia (2024).PMID:39610064
- Front Oncol 12 (2022):961653.PMID:36457504
- J Ethnopharmacol (2024):117865.PMID:38369066
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- J Oncol 2022 (2022).PMID:36281290
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- Environ Toxicol (2023).PMID:38069587
- Colloid Surface B (2025):114537.PMID:39879672
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Int. J. Mol. Sci. 26.9 (2025):4325.
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Bioengineering 9.9 (2022):433.PMID:36134979
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Food Biosci (2025):106564.
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Biochem Pharmacol (2024):116688.PMID:39617210
- Food Funct. (2025).
- Toxicology (2024):154018.PMID:39608440
- J oncol 2022 (2022).PMID:36385962
- Mol Carcinogen (2023).PMID:37750597
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- J Ethnopharmacol (2025):120157.PMID:40532799
- Arch Toxicol (2024):1-16.PMID:38971901
- Front. Pharmacol. 16 (2025):1613560.PMID:40822457
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Drug Des. Dev. Ther. (2025):5123-5141.PMID:40546656
- Glia (2025).PMID:40747821
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Clin Immunol (2024):110308.PMID:39002794
- Eur J Pharmacol 998 (2025):177497.PMID:40058753
- Int Immunopharmacol 165 (2025):115441.PMID:40911993
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Am J Physiol-Gastr L (2024).PMID:38742280
- J. Drug Delivery Sci. Technol. (2025):106841.
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- J Ethnopharmacol (2024):118685.PMID:39127116
- Macromol Biosci (2024):2400003.PMID:38597147
- Food Funct (2025).PMID:40421817
- Commun Biol 8.1 (2025):71.PMID:39820362
- Nutrients 17.5 (2025):923.PMID:40077793
- Life Sci 254 (2020):117793.PMID:32416164
- Chem-Biol Interact (2025):111702.PMID:40812562
- J Dent (2024):105436.PMID:39488296
- Pharmaceuticals-Base 18.8 (2025):1187.
- Cell Oncol (2025):1-17.PMID:41051595
- J Ethnopharmacol (2024):119073.PMID:39522846
- Mol Neurobiol (2025):1-16.PMID:40402409
- Biochem Pharmacol (2024):116438.PMID:39025409
- J Am Heart Assoc (2025):e040093.PMID:40767292
- Front Pharmacol 16 (2025):1613560.PMID:40822457
- Mol Neurobiol (2024):1-18.PMID:38995443
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- J Ethnopharmacol 347 (2025).PMID:40187623
- J Drug Deliv Sci Tec 107 (2025):106841.
- Front Nutr 12 (2025):1682308.PMID:41112749
- Invest Ophth Vis Sci 66.13 (2025).PMID:41099598
- Bioorg Chem (2025):108926.PMID:40907438
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Drug Des Dev Ther (2025):5123-5141.
- Acs Biomater Sci Eng (2024).PMID:39164198
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- J Ethnopharmacol (2024):118080.PMID:38521426
- Chem-Biol Interact (2025):111630.PMID:40609922
- Faseb J 38.7 (2024):e23591.PMID:38572579
- PLoS Pathog. 21.9 (2025):e1013492.PMID:40920846
- Environ Toxico (2024).PMID:38700384
- Exp Neurol (2025):115252.PMID:40221008
- Bioorg Chem (2025):108667.
- Transl Oncol 47 (2024):102042.PMID:38924847
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- J Drug Deliv Sci Tec 104 (2025) 106577.
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- J Agr Food Res (2025):101694.
- Eur J Pharmacol (2025):178123.PMID:40914268
- Int J Mol Sci 26.13 (2025):5999.
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- J Dent (2024):105436.PMID:39488296
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Virulence 16.1 (2025):2500493.PMID:40521898
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- Am J Physiol-Cell Ph (2024).PMID:39069827
- J Am Heart Assoc: 14.16 (2025):e040093.PMID:40767292
- Life Sci (2024):123148.PMID:39447733
- Int Immunopharmacol 163 (2025):115226.PMID:40663811
- Acs Appl Bio Mater (2024).PMID:38700956
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Arch Toxicol (2025):1-17.PMID:40464975
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- T Nonferr Metal Soc 35.8 (2025):2726-2733.
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Int Immunopharmacol 162 (2025):115151.PMID:40609203
- Bioorg Chem (2025):108656.
- Macromol Biosci (2024):2400003.PMID:38597147
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Ann Transl Med 10.24 (2022).PMID:36660714
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- J Inflamm Res (2024):8009-8026.PMID:39507268
- J Virol 99.8 (2025):e00498-25.PMID:40631894
- Sci Rep-Uk 15.1 (2025):30446.PMID:40830225
- Eur J Pharmacol (2025):177497.PMID:40058753
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Neurochem Res (2023):PMID:37127800
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Neuroscience (2023).PMID:37286157
- Brain Res Bull (2024):111165.PMID:39667505
- ACS Omega (2025).PMID:40686969
- Poultry Sci (2025):105818.
- Exp Cell Res (2025):114674.PMID:40683587
- Bba-Mol Basis Dis (2025):168050.PMID:40946874
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Biology 14.9 (2025)
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Iscience 28.7 (2025).
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- J Neuro Oncol (2023):1-16.PMID:37351767
- Front Oncol 14 (2024):1440906.PMID:39346724
- Probiotics Antimicro (2025):1-16.PMID:40366615
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Front Pharmacol 16 (2025):1517221.
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Sci Rep-Uk 15.1 (2025):24303.PMID:40624204
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Frontiers in Pharmacology 16 (2025):1547685.
- Zool Res 45.5 (2024).PMID:39147715
- Biomedicines 13.6 (2025):1315.PMID:40564034
- Ann Med 57.1 (2025):2523563.PMID:40579858
- Acs Omega (2025).
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Eur J Pharmacol (2024):176995.PMID:39277096
- Heliyon 8.11 (2022).PMID:36353164
- Sci Rep-Uk 15.1 (2025):25039.PMID:40646181
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Front. Pharmacol. 16 (2025):1545498.
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- J Biomed Mater Res A 113.3 (2025):e37893.PMID:40059713
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Ann Surg Oncol (2025):1-20.PMID:40887570
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Environ Toxicol (2024).PMID:39400944
- Exp Cell Res (2025):114674.PMID:40683587
- Mol Neurobiol (2025):1-20.PMID:40742404
- J Ovarian Res 18 (2025):168.PMID:40731365
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Bmc Genomics 26.1 (2025):706.PMID:40745632
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Front Genet 13 (2022):932973.PMID:36118847
- Front Genet 13 (2022):959109.PMID:36147489
- Sci Rep-Uk 15.1 (2025):27517.PMID:40721473
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Sci Rep-Uk 15.1 (2025):26300.PMID:40683918
- Zool Res 45.5 (2024):1001.PMID:39147715
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Sci Rep-Uk 15.1 (2025):794.
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- Heliyon (2024).PMID:38707472
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Biol 14.6 (2025):594.
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Cell Signal (2025):111815.PMID:40258578
- Pediatr Res (2024):1-10.PMID:38658662
- Cytokine 176 (2024):156507.PMID:38244240
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Endocrine (2024).PMID:38191984
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Gerontology (2024).PMID:38168028
- Oral Dis (2024).PMID:38168877
- Environ Toxicol (2023).PMID:37052456
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Probiotics Antimicro (2025):1-16.PMID:40366615
- J Inflamm Res (2024):8009-8026.PMID:39507268
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Metabolomics 20.5 (2024):112.PMID:39369160
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- J Oncol 2022 (2022).PMID:35518787
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Gene (2024):148399.PMID:38518902
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Toxicol Sci (2024):kfae054.PMID:38636494
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- J Cancer 15.5 (2024):1397.PMID:38356722
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Endocrine (2024):1-14.PMID:38378893
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Eur J Pharmacol (2025):177343.PMID:39900330
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Front Oncol 14 (2024):1471109.PMID:39582546
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Faseb J39.7 (2025):e70530.PMID:40193045
- J Immunother (2024):10-1097.PMID:38847148
- J Steroid Biochem (2023):106429.PMID:38035949
- J Mech Behav Biomed 167 (2025):106963.PMID:40120143
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- J Cancer 11.5 (2020):1162.PMID:31956362
- Sci Rep-Uk 15.1 (2025):18697.PMID:40436970
- Poultry Sci (2025):105339.PMID:40482626
- Microb Pathogenesis (2025):107720.PMID:40403987
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Food Chem Toxicol (2025):115488.PMID:40288513
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Brain Res Bull (2025):111245.PMID:39924054
- J Biol Chem (2024):107499.PMID:38944125
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Faseb J 39.16 (2025):e70961.PMID:40827901
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Mol Med Rep 31.5 (2025):138.PMID:40145553
- Molecules 30.3 (2025):549.PMID:39942654
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Gene (2023):148050.PMID:38042211
- Poultry Sci (2025):105339.
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Exp Cell Res (2025):114674.PMID:40683587
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Bmc Complement Med 24 (2024).PMID:38783288
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Pestic Biochem Phys (2025):106728.
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Biomarkers (2024):1-12.PMID:38568742
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Hum Mol Genet (2024):ddae122.PMID:39216871
- J Mol Histol (2024):1-8.PMID:38758519
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Mol Biotechnol (2024):1-15.PMID:38771419
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Shock 59.3 (2023):426-433.PMID:36609531
- Gene 932 (2025):148898.PMID:39209182
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Tissue Cell (2024):102477.PMID:39018712
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Microb Pathogenesis (2024):107055.PMID:39442820
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Cell Transplant 33 (2024).PMID:38334047
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Future Microbiol 0 (2024).PMID:38629914
- J Sci Food Agr (2024).PMID:39394871
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Shock (2023):10-1097.PMID:37988072
- Luminescence 39.1 (2024):e4671.PMID:38286599
- Integr Cancer Ther 24 (2025).PMID:40944546
- J Cancer 16.10 (2025):3048-3064.
- Mol Carcinogen (2025).PMID:40222040
- Cancer Res Commun (2025).PMID:40601866
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Front Mater 12 (2025):1568591.
- Funct Integr Genomic 25.1 (2025):1-17.PMID:40608130
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- ONCOL LETT 29.6 (2025):1-12
- Dis Markers 2022 (2022).PMID:35968506
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Tissue Cell (2025): 102903.
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- World J Gastro Oncol 17.3 (2025):102187.PMID:40092949
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Transbound Emerg Dis 2025.1 (2025).PMID:40692872
- Bmc Cancer 25.1 (2025):1205.PMID:40707929
- Bba-Mol Cell Biol L 1870.5 (2025):159631.PMID:40379088
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Plos One 20.8 (2025):e0329272.PMID:40758730
- Mol Carcinogen (2025).PMID:40794014
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Tissue Cell 80 (2023):102001.PMID:36565506
- Andrology-Us (2025).PMID:40862537
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- CURR DRUG DELIV (2025).PMID:39976030
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Int J Chronic Obstr (2025):623-639.
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- J Orthop Surg Res 20.1 (2025):443.PMID:40319252
- Comput Biol Chem (2025):108540.PMID:40483799
- Carcinogenesis (2025):bgaf030.
- Plos One 20.6 (2025):e0317930.PMID:40455747
- J Integr Complement (2025).PMID:40459144
- Toxicol Lett (2025).PMID:40412772
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Virus Res 313 (2022):198748.PMID:35304133
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Dis Markers 2022 (2022).PMID:35845132
- Microb Pathogenesis (2025):107720.PMID:40403987
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Cell Biochem Funct 43.7 (2025):e70097.PMID:40574709
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Biochem Bioph Res Co (2025):151972.
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Microvasc Res (2025):104833.PMID:40571189
- Dis Markers 2022 (2022).PMID:35845132
- METABOLITES 15.5 (2025):290.
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Toxicology Letters (2025).PMID:40854414
- J Mech Behav Biomed (2025):106963.
- Shock (2023):10-1097.PMID:37179246
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- J Pharm Pharmacol (2025):rgaf094.PMID:41042989
- Bmc Pregnancy Childb 25.1 (2025):1001.PMID:41034826
- Chem Biodivers (2025):e00918.PMID:40991575
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- Pathogens 14.2 (2025):182.
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Aesthet Plast Surg (2025):1-15.PMID:40180642
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Molecular brain 18.1 (2025):1-23.PMID:39962509
- Toxicol-Lett-(2025).PMID:40854414
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Clinics 77 (2022).PMID:35662010
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Technol Cancer Res T 19 (2020).PMID:33111613
- Int J Chronic Obstr (2025):623-639.PMID:40092321
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Curr Issues Mol Biol 47.5 (2025):314.PMID:40699713
- Arch Biochem Biophys 766 (2025):110352.PMID:39978618
- Heliyon (2024):.PMID:37461802
- S Afr J Bot 177 (2025):445-456.
- Pathol Res Pract (2025):156247.PMID:41045764
- Exp Eye Res (2025):110492.
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Toxicon (2025):108293.PMID:39999927
- Pathogens 14.2 (2025):182.
- Exp Eye Res (2025):110492.PMID:40541914
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Renal Failure 47.1 (2025):2548613.PMID:40887103
- Mol Med Rep 31.3 (2025):1-10.
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- RENAL FAILURE 47.1 (2025):2552913.PMID:40898827
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Brain Res (2025):149942.PMID:40930451
- Genomics (2025):111009.PMID:39864635
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- J Interf Cytok Res (2025).PMID:40512525
- Translational Cancer Research 14.8 (2025).PMID:40950680
- Vet Parasitol 331 (2024):110284.PMID:39126893
- EXP LUNG RES 51.1 (2025):79-92.PMID:40889519
- Transl Cancer Res 14.5 (2025):2594.PMID:40530117
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Andrologia 2025.1 (2025):4092625.
- Women's Health Reports 6.1 (2025):803-815.
- J Integr Complement (2025).PMID:40459144
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Chin J Integr Med (2024):1-11.PMID:38941045
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Hematology 30.1 (2025):2523082.PMID:40611540
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Vet Parasitol (2024):110284.PMID:39126893
- Peerj 13 (2025):e19550.PMID:40611940
- Biochem Bioph Res Co (2025):152500.PMID:40858065
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Immunobiology (2024):152832.PMID:38943814
- Oncol Lett 29.6 (2025):276.PMID:40247989
- Peerj 13 (2025):e19550.PMID:40611940
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- J Obstet Gynaecol Re PMID:39169658
- J Int Med Res 48.4 (2020).PMID:31891283
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Toxicon 257 (2025):108293.PMID:39999927
- Asian J Urol (2025).
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Cell J 24.1 (2022):15.PMID:35182060
- Transplant Direct 11.7 (2025):e1829.PMID:40590007
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- J Int Med Res 49.3 (2021).PMID:33730930
- Immunobiology (2025):153090.
- Biochem Genet (2023):1-18.PMID:37148331
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Anim Biotechnol (2023):1-12.PMID:36756956
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- TRANSL ANDROL UROL 14.2 (2025).PMID:40114844
- PeerJ 13 (2025):e19083.
- J Int Med Res 48.4 (2020).PMID:31891283
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Balk Med J 41.6 (2024).PMID:39319820
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Balk Med J 41.6 (2024):491.PMID:39319820
- Hematology 28.1 (2023):2220522.PMID:37272581
- Genes Genom (2023):1-15.PMID:37318704
- Cell J 25.8 (2023):554.PMID:37641417
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Comb Chem High T Scr (2024).PMID:35894460
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- World J Oncol (2024):.
- Oncol Res 33.1 (2024):103.PMID:39735676
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Open Life Sci. 20.1 (2025):20221056.
- J Obstet Gynaecol Re PMID:39169658
- Cancer Biomark 42.5 (2025):18758592241306263.
- Vet Microbiol (2025):110495.
- Particul Sci Technol (2025):1-13.
- Mol Cell Probe (2025):102031.
- Neuroreport 33.10 (2022):413.PMID:35623086
- Chin J Integr Med (2025):1-10.PMID:40338446
- Fitoterapia (2024):106245.PMID:39393711
- Cell J 24.1 (2022):15.PMID:35182060
- Transpl P 52.1 (2020):398-405.PMID:31928781
- J Cardiothorac Surg 20 (2025):270.PMID:40555993
- Iran J Immunol (2023).PMID:37865874
- J Herbs Spices Med P (2025):1-16.
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Crit Rev Eukar Gene (2025).
- Jove-J Vis Exp 220 (2025):e68581.
- J Cancer Metas Treat (2024).
- J Funct Foods 123 (2024):106621.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Front Pharmacol 15 (2024):1384141@0.jpg
- Biomedicines 12.11 (2024):2543.
- Mol Ther-Nucl Acids (2020).
- Pharmaceuticals-Base 17.10 (2024):1295.
- Int J Mol Sci 25.19 (2024):10496.
- New J Chem 48.11 (2024):5068-5073.
- Int J Bioprinting (2024).
- Phytother Res 34.4 (2020):836-845.
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Integr Med-Jim (2024).
- Netw Model Anal Hlth 13.1 (2024):1-15.
- J Nutr Biochem (2024):109769.PMID:9276944
- J Transl Med 22.1 (2024):1-16.
- Front Pharmacol 15:1453938.
- bioRxiv (2025):2025-08.
- Faseb J 38.15 (2024):e23876.
- Phytomedicine (2024):156091.
- bioRxiv (2025):2025-08.
- Bioact Mater 43 (2025):32-47.
- Int J Mol Sci 25.19 (2024):10339.
- Adv Funct Mater 29.50 (2019):1906690.
- BioRxiv (2025):2025-06.
- Chem Eng J (2024):156542.
- Cell Biomaterials (2025).
- Am J Cancer Res (2024):2852-2867.
- bioRxiv (2025):2025-01.
- Drug Des Dev Ther (2024):5841-5851.
- Heliyon (2024).
- Diss. University of Kansas, 2025.
- Rev Bras Farmacogn (2024):1-7.
- hLife (2024).
- Drug Resist Update (2024):101161.
- Mater Express 10.1 (2020):102-111.
- BioRxiv (2025):2025-01.PMID:39975379
- Am J Chinese Med (2025):1-20.PMID:40646505
- Cell Biomaterials (2025):
- Front Bioeng Biotech 12 (2024):1460870.
- Int J Mol Sci 25.20 (2024):11184.
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Bioorg Chem (2024):107731.
- Mater Res Express 7.2 (2020):025401.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Acs Appl Mater Inter (2024).PMID:39167710
- Carbohyd Polym (2024):122897.
- Biosens Bioelectron (2024):116875.
- Bioact Mater 44 (2025):220-235.
- Heliyon (2024).
- Mol Ther Nucl Acids (2020).
- Biomed Pharmacother 179 (2024):117370.
- scienceasia (2024).
- J Transl Med 22.1 (2024) 1-16.
- ACS Appl. Eng. Mater. (2025).
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Small (2024):2402308.PMID:3911
- bioRxiv (2025):2025-08.
- Gene (2024) 149056.
- J Hazard Mater (2024):136113.
- Acs Appl Nano Mater (2024).
- Front Oncol 10 (2020):387.
- Toxins 16.7 (2024):319.
- J Hazard Mater (2024) 135735.
- J Pharm Anal (2024):101053.
- Nutrients 16.14 (2024):2314.
- Nutrients 16.14 (2024):2346.
- Acs Omega (2024).
- Ecotox Environ Safe 286 (2024):117233.
- Seoul University Graduate Schoo2025.
- Heliyon (2024).
- Indian J Pharm Sci 86.3 (2024).
- J Tradit Compl Med (2024).
- BioRxiv (2025):2025-06.
- bioRxiv (2024) 2024-10.
- Int J Mol Sci 25.15 (2024):8340.
- Biol 14.7 (2025):780.PMID:40723340
- Antioxidants 13.11 (2024) 1320.
- Viruses 16.8 (2024):1239.
- Antioxidants-Basel 13.11 (2024):1289.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Mol Cell Toxicol (2022):1-11.
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Cancers 14.21 (2022):5218.PMID:36358640
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Cells 11.22 (2022):3580.PMID:36429010
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Adv Funct Mater (2023):2309690.
- Food Sci Nutr (2023).
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Mater Today Chem 27 (2023):101331.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Biocell 47.8 (2023).
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Ann Hematol (2023):1-12.
- Aquaculture 564 (2023):739060.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Crit Rev Eukar Gene 34 (2024).
- Phytomedicine (2024):155347.
- Viruses 14.8 (2022):1783.PMID:36016405
- Phytomedicine 103 (2022):154199.PMID:35679793
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Foods 11.11 (2022):1575.PMID:35681325
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Int J Mol Sci 25.2 (2024):919.
- Mater Today Adv 15 (2022):100271.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Sensors & Diagnostics (2024).
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Cancers 14.19 (2022):4645.PMID:36230568
- Phytomedicine 105 (2022):154330.PMID:35905566
- Adv Funct Mater (2024):2305827.
- J Oncol 2022 (2022).PMID:35909906
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Dis Markers 2022 (2022).
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- J Oncol 2022 (2022).PMID:36059813
- Molecules 27.16 (2022):5337.PMID:36014573
- Sensor Actuat B-Chem 381 (2023):133437.
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- bioRxiv (2024):2024-02.
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Adv Funct Mater (2023):2214998.
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Chem Eng J 474 (2023):145358.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- bioRxiv (2022):2022-04.
- Front Mar Sci 9 (2022):861117.
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Nanophotonics 11.22 (2022):5089-5100.
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Front Microbiol 14 (2023).PMID:37645224
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Iscience 26.9 (2023).PMID:37670789
- Crystals 13.7 (2023):1067.
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Appl Entomol Zool 58.4 (2023):303-313.
- Oncol Lett 26.1 (2023):1-17.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Front Immunol 14 (2023).PMID:37901236
- J Inflamm Res (2023):1045-1057.PMID:36936349
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Mol Med 29.1 (2023):6.PMID:36647009
- Biochip J (2023):1-10.
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Mol Cell Toxicol (2023):1-10.
- Int J Pept Res Ther 29.2 (2023):19.
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- View-China 4.2 (2023):20220052.
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- bioRxiv (2023):2023-05.PMID:37292976
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Microorganisms 11.9 (2023):2258.PMID:37764102
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Ceram Int 49.15 (2023):25953-25963.
- Mater Today Bio (2024):100958.
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Chin Herb Med (2024).
- HemaSphere 5.7 (2021).PMID:34136753
- Phytomedicine (2024):155656.
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Phytomedicine 86 (2021):153565.PMID:33945919
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- J Inflamm Res 14 (2021):2445.
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Adv Funct Mater (2024):2400489
- Pharmaceuticals-Base 17.4 (2024):515.
- Food Hydrocolloid 120 (2021):106980.
- Cells 13.9 (2024):728.
- J Clean Prod 315 (2021):128201.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Appl Entomol Zool (2022):1-14.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Transl Cancer Res 13.4 (2024).
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Acs Pharmacol Transl (2024).
- Phytomedicine (2024):155767.
- Acs Omega (2024).
- Talanta (2024):126381.
- Mol Cell Biochem (2024) 1-13.
- J Cancer 15.13 (2024):4244-4258.
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Heliyon (2024).
- Bladder 12.2 (2025):e21200036.PMID:40747461
- Int J Biol Macromol 307 (2025).PMID:40112979
- Pharmaceutics 16.6 (2024):744.
- Molecular Therapy Oncology (2024).
- Biomaterials 272 (2021):120757.PMID:33798960
- Theranostics 14.7 (2024):2687.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Front Pharmacol 11 (2021):618262.PMID:33551818
- J Biol Chem 297.2 (2021).PMID:33722608
- Phytomedicine (2024):155744.
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- bioRxiv (2024):2024-05.
- Fiber Polym (2022):1-9.
- Heliyon (2024).
- Acta Trop 232 (2022):106519.PMID:35584779
- Antioxidants Basel 13.3 (2024):264.
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Nano Today 43 (2022):101416.
- Mater Design (2024):112812.
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- J Funct Foods 114 (2024):106076.
- Front Oncol 12 (2022):851300.PMID:35392243
- Front Immunol 15 (2024):1326137.
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- New J Chem (2024).
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Kaohsiung J Med Sci (2024).PMID:38340032
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- J Ethnopharmacol (2024):117867.PMID: 38342155
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1347683.PMID:38343537
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Clin Transl Disc 2.2 (2022):e49.
- Tissue Cell 76 (2022).PMID:35182988
- Phytochem Lett 47 (2022):174-179.
- Biomed Res Int 2021 (2021).PMID:34373837
- Phytochem Lett 46 (2021):79-89.
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Cells 10.9 (2021):2399.PMID:34572049
- Nano Res (2022):1-8.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Bio-Des Manuf 5.2 (2022):358-370.
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- PeerJ 9 (2021):e11482.PMID:34820154
- Exp Ther Med 27.5 (2024):1-16.
- Tissue Cell 74 (2022):101680.PMID:34808429
- Nano Today 41 (2021):101326.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Int J Mol Sci 25.24 (2024):13439.
细胞计数试剂盒-8(CCK-8)使用WST-8(2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺酚基)-2H-tetrazolium,单钠盐),在存在电子载体1-Methoxy PMS的情况下,产生水溶性福尔马定染料进行方便的测定。 CCK-8溶液直接加入到细胞中,无需预先混合组分。 WST-8被细胞脱氢酶生物还原为可溶于组织培养液的橙色福尔马定产物。 产生的福尔马定量与活着的细胞数量成正比。由于CCK-8溶液非常稳定且具有很小的细胞毒性,因此可以进行更长时间(例如24至48小时)的孵育。
细胞计数试剂盒 - 8允许灵敏度高、用于增殖和毒性测定中确定存活细胞数量的显色法检测。 检测灵敏度比MTT、XTT或MTS等任何其他四唑盐都要高。

图1:Cell Counting Kit-8(CCK-8)的工作机制。
细胞数量确定
1.将细胞悬浮液(100μL/孔)接种在96洞孔板中。将板在潮湿的培养箱中预孵育(例如,在37℃,5%CO2下)。
2.向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
3.将培养板在培养箱中孵育1-4小时。
4.使用酶标仪测量450 nm处的吸光度。
细胞增殖和细胞毒性测定
1.将种子细胞以103-104个细胞/孔的密度在96孔板中在100μL培养基中培养。将细胞在CO2培养箱中于37℃培养24小时。
2.将不同浓度的待测物质加入板中。
3.将培养板在培养箱中孵育适当的时间(例如,6,12,24或48小时)。
4.使用重复移液器向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
5.将培养板在培养箱中孵育1-4小时。
6.在读取孔板之前,重要的是在轨道振动器上轻轻混合1分钟,以确保颜色均匀分布。
7.使用酶标仪测量450 nm处的吸光度。
数据分析
统计分析有几种方法,您可以选择使用O.D.值或细胞数量,我们提供其中一种方法。
细胞存活率(%)= [(As-Ab)/(Ac-Ab)]×100
抑制率(%)= [(Ac-As)/(Ac-Ab)]×100
As =实验孔吸光度(含有细胞,培养基,CCK-8和待测化合物的孔的吸光度)。
Ab =空白孔吸光度(含有培养基和CCK-8的孔的吸光度)。
Ac =对照孔吸光度(含有细胞,培养基和CCK-8的孔的吸光度)。
制作标准曲线
1. 细胞计数板计数细胞悬液中的细胞数。
2. 使用培养基,等比稀释细胞悬液为一个浓度梯度,通常需要5-7个浓度梯度,每组几个复孔。然后接种细胞。(注意每孔的细胞数量。如果您将细胞悬液稀释在管中,在加入培养板的孔之前,请小心再次混匀细胞。每孔中细胞悬液的体积应该是一致的。)
3. 培养直至细胞贴壁(通常2-4小时),然后每100 μl培养基加入10 μl CCK-8。继续孵育1-4小时,用酶标仪测量450nm处的吸光度。制作出一条以细胞数为X轴坐标,O.D.值为Y轴坐标的标准曲线。
可以基于该曲线确定待测样品的细胞数。使用此标准曲线的先决条件是培养检测条件相同。
注意事项
1. 确保药物和CCK8均匀分布在培养基中。
2. 细胞增殖越多, 颜色越深; 细胞毒性越强,颜色越浅。
3. 对于贴壁细胞,每孔至少需要1000个细胞(100 μl培养基)。对于白细胞,由于灵敏度较低,每孔至少需要2500个细胞(100 μl培养基)。推荐的96孔板每孔最大细胞数为25000。如果使用24孔或6孔板进行该检测,请计算相应的每孔的细胞数,并调整CCK-8的体积,使其为每孔总液体体积的10%。
4. 因为CCK8测定是基于活细胞中的脱氢酶活性,影响脱氢酶活性的条件或化学物质可能导致实际活细胞数与使用CCK-8测定活细胞数之间有差异。
5. WST-8可能与还原剂反应生成WST-8 formazan。如果使用还原剂 (例如一些抗氧化剂)会干扰检测。如果待检测体系中存在较多的还原剂,需设法去除。
6. 孵育2小时后,背景O.D.值一般为0.1-0.2单位。
7. 注意不要在孔中引入气泡,因为它们会干扰O.D.值。
8. 如果您想对CCK8溶液进行灭菌,请使用0.2 μm的膜过滤溶液。
9. 孵育时间因孔中细胞的类型和数量而异。通常,白细胞着色较弱,因此可能需要较长的孵育时间(长达4小时)或大量细胞(~105细胞/孔)。
10. 如果细胞悬液中存在高浊度, 测量并减去样品在600nm或更高波长的O.D值。
11. CCK8不能用于细胞染色。
12. 培养基中的酚红不会影响实验结果,酚红的吸光度可以在计算时,通过扣除空白孔中本底的吸光度而消去,因此不会对检测造成影响。
13. CCK8的毒性非常低,在CCK8测定完成后,相同的细胞可用于其他细胞增殖测定,例如结晶紫测定,中性红测定或DNA荧光测定。(除非细胞极为稀少,不推荐。)
14. 该试剂盒可用于大肠杆菌,但不能用于酵母细胞。
15. 在读取平板之前,您可以在摇床上轻柔混匀。
16. 我们建议将细胞接种在靠近培养板中央的孔中,最外围一圈孔中的培养基容易蒸发,可以用PBS,水或培养基填充这些孔。
17. 如果您没有450nm滤光片。您也可以使用吸光度在430和490nm之间的滤光片, 450nm滤光片具有最佳灵敏度。
18. 测量450nm处的吸光度,如果您需要进行双波长测定,作为参考波长可以测定650nm处的吸光度。
19. 药物中金属离子的存在可能会影响CCK8的灵敏度。终浓度为1mM的氯化亚铅、氯化铁、硫酸铜会抑制 5%、15%、 90% 的显色反应,使灵敏度降低。如果终浓度是10mM的话,将会100%抑制。
常见问题
Q:如何做空白对照?
A:可以用加相应量细胞培养基和CCK-8但不加细胞的孔作为空白对照,若担心所使用的药物会干扰检测,需设置加相应量细胞培养液、药物和CCK-8但不加细胞的孔作为空白对照。
Q:只加CCK-8不加细胞的空白孔,数值上增?
A:在整个实验过程中,随着时间的增加,如果细胞培养时间较长,请注意蒸发问题。因为反应环境温度较高,会有部分液体挥发。空白组虽然没有细胞,但是随着液体的挥发,药物浓度相当于提高了,所以空白对照的数值也会有轻微的变化(但不会有明显的变化)。如果很在意空白对照的数值,可将96孔板外围一圈加培养基、水或PBS 保湿。同时,可以把96孔板置于培养箱内靠近水盘的位置以缓解蒸发。将96孔板外围两圈用PBS铺板,这样挥发先挥发周边的,可以对内部及空白对照的影响降至最低。
Q:一般多久测一次值?
A:预实验时可以在0.5、1、2和4小时后分别用酶标仪检测,然后选取吸光度范围比较适宜的一个时间点用于后续实验。
Q:加入CCK8后暂时不测OD值,可以如何处理暂时保存?能够保存多久?
A:如果需要暂时不测定OD值,可以向每孔中加入10ul 0.1M HCl溶液或者1% w/v的SDS溶液,避光保存在室温,24小时内吸光度不会发生变化。
Q:如何保存?
A:CCK-8溶液在避光、0-5℃的条件下可以保存1 年,若长期不用可在-20℃下避光保存2年。建议分装后保存于-20℃,使用时提前于4℃解冻,请避免反复冻融,否则增加背景值,干扰实验结果。
Q:是否需要更换培养基?
A:不需要,若药物影响比较小的情况可以不更换培养基,直接扣除培养基中加入药物后的空白吸收即可。
Q:待测物质有氧化性或还原性该做何处理?
A:本试剂盒的检测依赖于脱氢酶催化的反应,如果待测物质有氧化性或还原性,可在加CCK-8之前更换新鲜培养基,去掉药物的影响。
如果实验中有还原剂,请检查背景的OD值,即在不含细胞的培养基中加入药物,然后加入CCK-8试剂在一定时间内检测,和不加药物的培养基进行比较(只有CCK-8试剂),如果O.D值明显偏高,则说明有反应。
Q:如果培养基颜色或PH已变化,是否需要更换新的培养基?
A:加入CCK-8时,如果细胞培养时间较长,培养基颜色或pH值已变化,建议换用新鲜的培养基。
Q:适用细胞?
A:因为测线粒体酶,所以真核细胞,有线粒体的均可,例如单细胞,动物细胞。但有细胞壁的细胞,例如植物细胞,酵母细胞,底物进入细胞效率低,不推荐。
Q:线性不佳原因?
A:细胞不均;培养液蒸发;还原剂;气泡;孔板周围一圈不能用,除非只培养少于一天的时间;细胞数目很重要,太少信号会低。
Q:金属毒性?
A:可以检测金属毒性,最好做空白对照。
Q:适用于那些细胞?其他还有哪些细胞可用?生物被膜内的活菌 (流感嗜血杆菌和绿脓杆菌)?
A:所有哺乳动物的细胞,细菌一般没有检测CCK8的,可以染色法,或者流式,最常规的方法,有报道, 比浊法测OD600。
Q:是否可以替代Brud或EDU法检测细胞增殖?
A:虽然CCK8通过检测对生长期的细胞内的脱氢酶来反应细胞的活性,而胸腺嘧啶插入法通过核苷酸类似物的方式插入合成的DNA来检测细胞的活性,这几种方法是有一定关联性的,CCK8可替换胸腺嘧啶插入法来检测细胞增殖,并且检测更方便。
Q:空白孔数值偏高,有可能是培养基长菌吗?或者其他原因?
A:空白孔数值偏高一般认为染菌造成的,很少出现这种问题。
Q:CCK8能检测组织吗
A:不能检测组织。
Q:是否可以检测T细胞
A:可以,T细胞长的慢,需延长孵育时间。
Q:当两个细胞混合培养时(骨髓间充质细胞,另一个是悬浮T细胞),培养一段时间后,只测骨髓间充质干细胞的生长、增殖情况,请问用CCK-8能测吗?怎么做?
A:对于两种细胞的情况:
1)如果测定贴壁细胞的生长状况,那么可以把悬浮的T细胞转移掉,使用上述第二种方法测定。
2)如果T细胞对于间充质细胞的生长很关键,不能取走,那么测定的活性程度是总量,此时,需要对每一个孔的T细胞进行估算,如果每个培养条件下T细胞总量接近,或者T细胞含量很少,远远小于间充质细胞,也可以测定,使用对照孔可以去除T细胞的影响。
3)如果T细胞可以短时间内除去,可以找个灵敏度高的CCK-8,信号强,建议细胞量合适的情况下(每一个孔10000个),30分钟左右出读数结果,测 定后,可以将T细胞再加入培养孔。 这样做对细胞的生长影响不大。但是如果做动力学,那么要考虑的因素多一些。
Q:CCK-8是通过和细胞内的脱氢酶反应而反映着细胞数量,假如细胞已经死亡,而脱氢酶活性还有,那么如何计算细胞数量?
A:多数情况下,细胞死亡过程中,细胞内的成分会降解,脱氢酶会有部分释放,但是活性和活细胞比,比较低。举例说:100个细胞死亡20小时后,释放的脱氢酶活力,不足5个活细胞的脱氢酶活力,也就是说,这种情况带来的误差5%以内。而且,这种细胞死亡,对同种细胞来说,情况是一样的,一般都是在不同的孔间比较同种细胞,所以系统误差是一样的,即系统误差会彼此消减。
| 应用&特点 |
1) 细胞增殖测定 - GlpBio细胞计数试剂盒-8(CCK-8)是水溶性的,在培养中是稳定的,并且是无毒的。 2) 细胞活力测定 - 代谢活性和染料产生与改变的活力成比例地变化。 3) 细胞因子测定 - 测量细胞因子诱导的增殖。如果需要,可以在研究结束时回收细胞并扩增。 4) 细胞毒性测定 - 来自细胞毒性化学物质的细胞死亡对颜色发展没有影响,只有活细胞将试剂转化为比色指示剂。试剂本身具有可忽略的毒性,并且通常对细胞是安全的。 |
| 运输方式 | 蓝冰运输。 |
| 储存条件 | 储存在4°C避光,可稳定长达12个月。储存在-20°C避光,可稳定长达2年。 |
| 用途 | 仅供研究使用!不能用于人体。 |
| CCK-8 | MTT | MTS | SRB |
| Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
| Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
| Character | Liquid | Solid | Liquid | Liquid |
| Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
| Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
| Convenience | +++ | ++ | +++ | + |
| Detection speed | +++ | + | ++ | + |
| Repeatability | +++ | + | ++ | ++ |
| Stability | ++ | + | + | +++ |
-
Related Biological Data

Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data

LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data

Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data

Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data

Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data

H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data

After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data

Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.